Newsroom

Sorted by: Latest

-

Lost Money on Abacus Global Management, Inc. Shares? The Law Offices of Frank R. Cruz Investigates Potential Securities Fraud After 37.69% Stock Decline

LOS ANGELES--(BUSINESS WIRE)--Abacus Global Management, Inc. ("Abacus Global" or the "Company") investors who lost money may have claims to recover their losses. The Law Offices of Frank R. Cruz today announced it is investigating potential securities fraud claims on behalf of investors in Abacus Global Management, Inc. (NYSE: ABX), examining whether the Company may have violated the federal securities laws.If you lost money on Abacus Global Management, Inc. securities, share your Abacus Global...
-

Auna Announces 3Q26 Financial Results

LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today unaudited financial results for the third quarter ended September 30, 2026 (“Third quarter 2026” or “3Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 3Q’26 Consolid...
-

Guerrilla RF Announces Uplisting to The Nasdaq Stock Market

GREENSBORO, N.C.--(BUSINESS WIRE)--Guerrilla RF, Inc. (OTCQX: GUER), a leading provider of high-performance RF and microwave semiconductors, today announced that its common stock has been approved for uplisting to The Nasdaq Capital Market (“Nasdaq”) under the Company’s existing ticker symbol, “GUER.” The Company's common stock is expected to begin trading on Nasdaq on November 18, 2026. Shareholders are not required to take any action as a result of the uplisting.“The uplisting to Nasdaq is an...
-

Merck Announces Update on BELLWAVE Clinical Development Program Evaluating Nemtabrutinib

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the discontinuation of the clinical development program evaluating nemtabrutinib (MK-1026), an investigational, oral, non-covalent Bruton's tyrosine kinase (BTK) inhibitor. Nemtabrutinib is being evaluated for patients with chronic lymphocytic leukemia (CLL), small lymphocytic leukemia (SLL) and other hematologic malignancies in the BELLWAVE program. Merck is discontinuing the...
-

York Space Systems to Hold Investor Call to Discuss York’s Unmanned Space Architecture and Planned Outlook Acquisition

DENVER--(BUSINESS WIRE)--York Space Systems to Hold Investor Call to Discuss York’s Unmanned Space Architecture and Planned Outlook Acquisition...
-

Ibotta Appoints Kamelia Aryafar to Board of Directors

DENVER--(BUSINESS WIRE)--Ibotta, Inc. (NYSE: IBTA), North America’s leading digital promotions network, today announced the appointment of Kamelia Aryafar to its Board of Directors. Kamelia brings more than 15 years of experience researching and building AI for leading consumer and enterprise applications across consumer technology, e-commerce, and enterprise software. With her appointment, Larry W. Sonsini has stepped down from Ibotta’s Board, effective November 15, 2026. Kamelia is the Head o...
-

Samenvatting: Tractivity sluit zich aan bij European Technology Group om de betrokkenheid van belanghebbenden in heel Europa te versterken

LONDEN & HULL, Verenigd Koninkrijk--(BUSINESS WIRE)--European Technology Group (ETG), een Europees GovTech-platform met een langetermijnvisie, verwelkomt Tractivity, een van de toonaangevende leveranciers van software voor stakeholderrelatiebeheer in Europa, in zijn familie. De transactie markeert de volgende fase in de ontwikkeling van Tractivity na een periode van aanhoudende groei. Het bedrijf bedient meer dan 100 organisaties in Europa, onder meer in de energiesector, de nutsbedrijven, de g...
-

Resumen: Tractivity se une a European Technology Group para reforzar la participación de los actores parte en toda Europa

LONDRES Y HULL, Reino Unido--(BUSINESS WIRE)--European Technology Group (ETG), plataforma europea de GovTech orientada al largo plazo, da la bienvenida a su familia a Tractivity, proveedor líder en Europa de software de gestión de relaciones con los actores parte. Esta operación marca la siguiente fase del desarrollo de Tractivity después de un crecimiento sostenido. La empresa presta servicio a más de 100 organizaciones de los sectores de la energía, los servicios públicos, la sanidad, la admi...
-

Riassunto: Tractivity entra a far parte di European Technology Group per rafforzare il coinvolgimento degli stakeholder in tutta Europa

LONDRA e HULL, Regno Unito--(BUSINESS WIRE)--European Technology Group (ETG), una piattaforma europea GovTech orientata al lungo termine, dà il benvenuto nella propria famiglia a Tractivity, un fornitore leader di software per la gestione delle relazioni con gli stakeholder in Europa. La transazione segna la prossima fase dello sviluppo di Tractivity dopo un periodo di crescita sostenuta. L'azienda si rivolge a più di 100 organizzazioni nei settori di energia, servizi pubblici, assistenza sanit...
-

Golub Capital BDC, Inc. Announces Fiscal Year 2026 Fourth Quarter Financial Results

NEW YORK--(BUSINESS WIRE)--Golub Capital BDC, Inc., a business development company (Nasdaq: GBDC), today announced its financial results for its fourth fiscal quarter ended September 30, 2026. Except where the context suggests otherwise, the terms “we,” “us,” “our,” and “Company” refer to Golub Capital BDC, Inc. and its consolidated subsidiaries. “GC Advisors” refers to GC Advisors LLC, our investment adviser. SELECTED FINANCIAL HIGHLIGHTS               (in thousands, except per share data)    ...